Thorough QT/QTc Study to Evaluate the Effects of Ecopipam (EBS-101) on Cardiac Repolarization

NCT05841160 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

29

Enrollment

INDUSTRY

Sponsor class

Conditions

QT/QTc

Interventions

DRUG: Ecopipam Hydrochloride
DRUG: Moxifloxacin
DRUG: Placebo

Sponsor

Emalex Biosciences Inc.

Collaborators

[object Object]
[object Object]